HAVAS NV (HAVAS.AS) Stock Fundamental Analysis

AMS:HAVAS • NL0015002K83

17 EUR
0 (0%)
Last: Feb 20, 2026, 07:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to HAVAS. HAVAS was compared to 67 industry peers in the Media industry. HAVAS has only an average score on both its financial health and profitability. HAVAS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • HAVAS had positive earnings in the past year.
  • In the past year HAVAS had a positive cash flow from operations.
HAVAS.AS Yearly Net Income VS EBIT VS OCF VS FCFHAVAS.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 100M 200M 300M

1.2 Ratios

  • HAVAS has a Return On Assets (2.65%) which is comparable to the rest of the industry.
  • The Return On Equity of HAVAS (10.20%) is better than 63.64% of its industry peers.
  • HAVAS has a Return On Invested Capital of 9.60%. This is amongst the best in the industry. HAVAS outperforms 81.82% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for HAVAS is in line with the industry average of 8.40%.
  • The 3 year average ROIC (8.24%) for HAVAS is below the current ROIC(9.60%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.65%
ROE 10.2%
ROIC 9.6%
ROA(3y)2.51%
ROA(5y)N/A
ROE(3y)9.01%
ROE(5y)N/A
ROIC(3y)8.24%
ROIC(5y)N/A
HAVAS.AS Yearly ROA, ROE, ROICHAVAS.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2 4 6 8

1.3 Margins

  • The Profit Margin of HAVAS (6.06%) is better than 69.70% of its industry peers.
  • HAVAS has a better Operating Margin (11.77%) than 74.24% of its industry peers.
Industry RankSector Rank
OM 11.77%
PM (TTM) 6.06%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HAVAS.AS Yearly Profit, Operating, Gross MarginsHAVAS.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2 4 6 8 10

4

2. Health

2.1 Basic Checks

  • HAVAS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, HAVAS has about the same amount of shares outstanding.
  • Compared to 1 year ago, HAVAS has an improved debt to assets ratio.
HAVAS.AS Yearly Shares OutstandingHAVAS.AS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
HAVAS.AS Yearly Total Debt VS Total AssetsHAVAS.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • HAVAS has an Altman-Z score of 0.36. This is a bad value and indicates that HAVAS is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.36, HAVAS is not doing good in the industry: 75.76% of the companies in the same industry are doing better.
  • HAVAS has a debt to FCF ratio of 3.13. This is a good value and a sign of high solvency as HAVAS would need 3.13 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.13, HAVAS is in the better half of the industry, outperforming 71.21% of the companies in the same industry.
  • HAVAS has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
  • HAVAS's Debt to Equity ratio of 0.14 is amongst the best of the industry. HAVAS outperforms 80.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 3.13
Altman-Z 0.36
ROIC/WACC1.17
WACC8.18%
HAVAS.AS Yearly LT Debt VS Equity VS FCFHAVAS.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 0.83 indicates that HAVAS may have some problems paying its short term obligations.
  • The Current ratio of HAVAS (0.83) is worse than 60.61% of its industry peers.
  • HAVAS has a Quick Ratio of 0.83. This is a bad value and indicates that HAVAS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HAVAS has a Quick ratio of 0.80. This is comparable to the rest of the industry: HAVAS outperforms 42.42% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.8
HAVAS.AS Yearly Current Assets VS Current LiabilitesHAVAS.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1B 2B 3B 4B

0

3. Growth

3.1 Past

  • HAVAS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -55.27%.
  • The Revenue has decreased by -0.31% in the past year.
EPS 1Y (TTM)-55.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.17%
Revenue 1Y (TTM)-0.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.07%

3.2 Future

  • HAVAS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.93% yearly.
  • The Revenue is expected to decrease by -0.06% on average over the next years.
EPS Next Y5.98%
EPS Next 2Y7.68%
EPS Next 3Y7.28%
EPS Next 5Y3.93%
Revenue Next Year1.3%
Revenue Next 2Y1.53%
Revenue Next 3Y1.79%
Revenue Next 5Y-0.06%

3.3 Evolution

HAVAS.AS Yearly Revenue VS EstimatesHAVAS.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
HAVAS.AS Yearly EPS VS EstimatesHAVAS.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.60, the valuation of HAVAS can be described as reasonable.
  • Based on the Price/Earnings ratio, HAVAS is valued a bit cheaper than 74.24% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.99, HAVAS is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 7.57, the valuation of HAVAS can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HAVAS indicates a rather cheap valuation: HAVAS is cheaper than 83.33% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, HAVAS is valued rather cheaply.
Industry RankSector Rank
PE 9.6
Fwd PE 7.57
HAVAS.AS Price Earnings VS Forward Price EarningsHAVAS.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 72.73% of the companies in the same industry are more expensive than HAVAS, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, HAVAS is valued a bit cheaper than the industry average as 69.70% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.27
EV/EBITDA 4.42
HAVAS.AS Per share dataHAVAS.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • HAVAS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.61
PEG (5Y)N/A
EPS Next 2Y7.68%
EPS Next 3Y7.28%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.71%, HAVAS is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 3.31, HAVAS pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.81, HAVAS pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.71%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
HAVAS.AS Yearly Dividends per shareHAVAS.AS Yearly Dividends per shareYearly Dividends per share 2025 0.2 0.4 0.6

5.3 Sustainability

DPN/A
EPS Next 2Y7.68%
EPS Next 3Y7.28%
HAVAS.AS Yearly Income VS Free CF VS DividendHAVAS.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2022 2023 2024 100M 200M 300M

HAVAS NV

AMS:HAVAS (2/20/2026, 7:00:00 PM)

17

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-17
Earnings (Next)04-07
Inst Owners28.58%
Inst Owner ChangeN/A
Ins Owners2.67%
Ins Owner ChangeN/A
Market Cap1.69B
Revenue(TTM)2.90B
Net Income(TTM)176.00M
Analysts83.75
Price Target20.43 (20.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.71%
Yearly Dividend2.53
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.94%
PT rev (3m)980.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)884.53%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE 9.6
Fwd PE 7.57
P/S 0.58
P/FCF 7.27
P/OCF 6.29
P/B 0.98
P/tB N/A
EV/EBITDA 4.42
EPS(TTM)1.77
EY10.41%
EPS(NY)2.25
Fwd EY13.21%
FCF(TTM)2.34
FCFY13.76%
OCF(TTM)2.7
OCFY15.9%
SpS29.29
BVpS17.39
TBVpS-8.16
PEG (NY)1.61
PEG (5Y)N/A
Graham Number26.32
Profitability
Industry RankSector Rank
ROA 2.65%
ROE 10.2%
ROCE 14.38%
ROIC 9.6%
ROICexc 11.32%
ROICexgc N/A
OM 11.77%
PM (TTM) 6.06%
GM N/A
FCFM 7.99%
ROA(3y)2.51%
ROA(5y)N/A
ROE(3y)9.01%
ROE(5y)N/A
ROIC(3y)8.24%
ROIC(5y)N/A
ROICexc(3y)9.34%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.32%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 3.13
Debt/EBITDA 0.51
Cap/Depr 32.43%
Cap/Sales 1.24%
Interest Coverage 7.6
Cash Conversion 59.16%
Profit Quality 131.82%
Current Ratio 0.83
Quick Ratio 0.8
Altman-Z 0.36
F-Score8
WACC8.18%
ROIC/WACC1.17
Cap/Depr(3y)29.4%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.25%
Cap/Sales(5y)N/A
Profit Quality(3y)166.07%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.17%
EPS Next Y5.98%
EPS Next 2Y7.68%
EPS Next 3Y7.28%
EPS Next 5Y3.93%
Revenue 1Y (TTM)-0.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.07%
Revenue Next Year1.3%
Revenue Next 2Y1.53%
Revenue Next 3Y1.79%
Revenue Next 5Y-0.06%
EBIT growth 1Y4.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40.63%
EBIT Next 3Y15.3%
EBIT Next 5Y8.82%
FCF growth 1Y-32.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.03%
OCF growth 3YN/A
OCF growth 5YN/A

HAVAS NV / HAVAS.AS FAQ

Can you provide the ChartMill fundamental rating for HAVAS NV?

ChartMill assigns a fundamental rating of 4 / 10 to HAVAS.AS.


What is the valuation status of HAVAS NV (HAVAS.AS) stock?

ChartMill assigns a valuation rating of 6 / 10 to HAVAS NV (HAVAS.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for HAVAS NV?

HAVAS NV (HAVAS.AS) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for HAVAS stock?

The Price/Earnings (PE) ratio for HAVAS NV (HAVAS.AS) is 9.6 and the Price/Book (PB) ratio is 0.98.


What is the financial health of HAVAS NV (HAVAS.AS) stock?

The financial health rating of HAVAS NV (HAVAS.AS) is 4 / 10.